glp 1 drugs and bipolar disorder Glucagon-like peptide-1 receptor agonists risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study Comparing Ozempic, Wegovy and Other

Slows Gastric Emptying GLP-1 medications slow the rate at which the stomach empties, suppressing appetite and leading to subsequent weight loss

These programs may provide: Copay cards Reduce out-of-pocket costs for insured patients Free medication programs For patients meeting income requirements Sliding scale pricing Adjusted costs based on financial need Compounding Pharmacies Some compounding pharmacies create customized versions of GLP-1 medications that may cost less than brand-name options

doi: 10.1016/j.tem.2018.08.005 55 HoegerKMDokrasAPiltonenT

How to Switch The transition is straightforward: Stopping Saxenda: No taper required Can stop after last daily dose No withdrawal effects Starting semaglutide: Begin at starting dose (0.25mg weekly) Follow standard titration schedule Some providers start at higher doses for patients switching from other GLP-1s, but standard titration is safest Timing: Can start semaglutide the week after stopping Saxenda No mandatory washout period Some providers start immediately after last Saxenda dose What to Expect During transition: Appetite suppression may temporarily decrease during early semaglutide titration GI side effects may recur as you adjust to new medication Full semaglutide effect takes 4-5 months to reach After transition: Most patients see additional weight loss beyond what Saxenda achieved Weekly dosing is typically more convenient Similar ongoing management Transition Considerations Timing expectations: Dont expect immediate additional weight loss Titration period is necessary even for patients experienced with GLP-1s Full benefit of switch becomes apparent at maintenance doses Managing expectations: Some initial adjustment period is normal The convenience benefit is immediate Weight loss benefit develops over months Practical Considerations for Each Medication Understanding day-to-day use helps set expectations

Some anti-diabetic medications are linked with an increased risk of weight gain or hypoglycemia which may reduce the efficacy of the intended anti-hyperglycemic effects of these therapies